Table 2: Histopathologic Diagnosis and Incident Rates of HPV Types 16 and 18 in the Study Population

Diagnosis No. Cases n (%) HPV 16 and/or 18 Prevalence with Luminex (%) (a) HPV 16 and/or 18 Prevalence with RLB (%) (b)
Negative pathology 41 (25.6) 80.5 33.3
Low-grade cervical lesions (c) 56 (35) 83.9 43.4
High-grade cervical lesions (d) 49 (30.6) 91.8 67.5
Cervical cancer 14 (8.8) 100 66.6
Total 160 (100) - -

(a) HPV genotyping with Luminex xMAP technology as described in Materials and Methods.
(b) HPV genotyping with RLB as described in Materials and Methods.
(c) Low grade cervical lesions: CIN I.
(d) High grade cervical lesions: CIN II, CIN III.